+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vaccines Market - Global Forecast 2026-2032- Product Image
Vaccines Market - Global Forecast 2026-2032- Product Image
New

Vaccines Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985895
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vaccines market is experiencing significant structural changes, shaped by advances in technology, evolving regulations, and a growing focus on global health initiatives. Senior leaders in the healthcare sector must navigate new complexities and opportunities as innovation and policy shifts accelerate momentum across the vaccine industry.

Market Snapshot: Global Vaccines Market Size and Growth Trajectory

The Vaccines Market grew from USD 90.21 billion in 2025 to USD 97.14 billion in 2026. It is expected to continue growing at a CAGR of 7.76%, reaching USD 152.31 billion by 2032. This upward trajectory reflects sustained investments, rapid technology adoption, and the strategic drive to improve immunization worldwide.

Scope & Segmentation

This comprehensive report provides analysis across a range of segments and technological innovations central to current and future vaccine strategies.

  • Vaccine Types: Inactivated, live-attenuated, messenger RNA, subunit/recombinant, polysaccharide, conjugate, toxoid, and viral vector vaccines.
  • Product Types: BCG, COVID-19, DPTa, hepatitis A and B, HPV, influenza, Japanese encephalitis, measles-mumps-rubella, and rotavirus vaccines.
  • Formulations: Monovalent and multivalent offerings targeting both broad and specific immunization needs.
  • Classification: Preventive versus therapeutic vaccines, with a focus on developments for infectious diseases and chronic/oncology indications.
  • Administration Routes: Intramuscular, intranasal, oral, and subcutaneous delivery methods, each influencing distribution and patient compliance strategies.
  • Dosage Presentations: Single-dose and multi-dose configurations tailored to varying healthcare infrastructure and population needs.
  • Age Groups: Adult, geriatric, pediatric, with emphasis on infant and toddler segments reflecting evolving immunization recommendations.
  • End Users: Academic and research institutes, hospitals and clinics, and dedicated vaccination centers supporting widespread rollout.
  • Regions: Americas, EMEA (Europe, Middle East, Africa), and Asia-Pacific, each with unique market dynamics and policy frameworks.
  • Technology: Digital health solutions, real-time data analytics, and advanced manufacturing platforms enabling efficient production and monitoring.

Key Takeaways for Senior Decision-Makers

  • Emerging vaccine platforms are transforming research, production, and delivery capabilities, creating new partnership and investment opportunities.
  • Streamlined regulatory processes are accelerating technology approvals and enabling agile response to public health emergencies.
  • Data-driven systems and digital infrastructure enhance surveillance, distribution, and adverse event management, supporting strategic planning and risk reduction.
  • Public-private collaboration is increasingly vital to ensuring equitable vaccine access and improving supply chain resilience, particularly in previously underserved markets.
  • Understanding nuanced patient demographics and evolving disease profiles will be critical in tailoring vaccine portfolios and maximizing market impact.
  • Responsive adaptation to regulatory, trade, and market shifts will define competitive positioning over the next decade.

Analyzing the Impact of 2025 United States Tariffs on Vaccine Supply Chains

The 2025 introduction of United States tariffs on vaccine-related imports has prompted significant reassessment of global sourcing and supply strategies. Manufacturers responded by redirecting procurement, initiating nearshoring, and investing in regional production to mitigate direct tariff exposure. Cost absorption strategies varied, with some producers maintaining stable pricing, while others adjusted downstream. These shifts altered contracting norms and incentivized long-term agreements to manage tariff risks. Logistics providers optimized transport plans to keep immunization timelines steady. Stakeholders are diversifying supplier networks and engaging in policy advocacy to address trade impacts and strengthen overall resilience.

Methodology & Data Sources

The report synthesizes insights from primary interviews with industry leaders, regulatory officials, and healthcare operators. It incorporates secondary data from peer-reviewed studies, industry white papers, official filings, and specialized databases. All findings undergo stringent validation, scenario analysis, and cross-referencing to ensure reliability and actionable intelligence.

Why This Report Matters

  • Leaders gain a structured view of global, regional, and segment-specific vaccine trends, supporting confident investment and policy decisions.
  • Strategic insights on regulatory and market dynamics equip organizations to respond proactively to emerging challenges and opportunities.
  • Stakeholders can benchmark their supply chain, partnership, and product strategies against evolving best practices across the global immunization landscape.

Conclusion

The vaccines market is redefined by scientific innovation, adaptive regulation, and shifting demographics. Success now depends on agile strategy, data-driven decision-making, and robust collaboration across the value chain.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Vaccines Market, by Type
8.1. Inactivated Vaccines
8.2. Live-Attenuated Vaccines
8.3. Messenger RNA Vaccines
8.4. Subunit, Recombinant, Polysaccharide, & Conjugate Vaccines
8.5. Toxoid Vaccines
8.6. Viral Vector Vaccines
9. Vaccines Market, by Vaccine Combination
9.1. Mono-Valent Vaccines
9.2. Multi-Valent Vaccines
10. Vaccines Market, by Disease Indication
10.1. Infectious Disease Vaccines
10.1.1. Influenza
10.1.2. Hepatitis A & B
10.1.3. Polio
10.1.4. COVID-19
10.1.5. Pneumococcal & Meningococcal Disease
10.1.6. Human Papillomavirus HPV
10.1.7. Rotavirus
10.1.8. Dengue
10.1.9. Malaria
10.1.10. Rabies
10.2. Non-Infectious Disease Vaccines
10.2.1. Cancer Vaccines
10.2.2. Allergy Vaccines
10.2.3. Alzheimer’s Vaccines
11. Vaccines Market, by Vaccine Classification
11.1. Preventive Vaccines
11.2. Therapeutic Vaccines
12. Vaccines Market, by Route of Administration
12.1. Intramuscular
12.2. Intranasal
12.3. Oral
12.4. Subcutaneous
13. Vaccines Market, by Dosage
13.1. Multi Dose
13.2. Single Dose
14. Vaccines Market, by Age Group
14.1. Adult
14.2. Geriatric
14.3. Pediatric
14.3.1. Infants
14.3.2. Toddlers
15. Vaccines Market, by End User
15.1. Academic & Research Institutes
15.2. Hospitals & Clinics
15.3. Vaccination Centers
16. Vaccines Market, by Region
16.1. Americas
16.1.1. North America
16.1.2. Latin America
16.2. Europe, Middle East & Africa
16.2.1. Europe
16.2.2. Middle East
16.2.3. Africa
16.3. Asia-Pacific
17. Vaccines Market, by Group
17.1. ASEAN
17.2. GCC
17.3. European Union
17.4. BRICS
17.5. G7
17.6. NATO
18. Vaccines Market, by Country
18.1. United States
18.2. Canada
18.3. Mexico
18.4. Brazil
18.5. United Kingdom
18.6. Germany
18.7. France
18.8. Russia
18.9. Italy
18.10. Spain
18.11. China
18.12. India
18.13. Japan
18.14. Australia
18.15. South Korea
19. United States Vaccines Market
20. China Vaccines Market
21. Competitive Landscape
21.1. Market Concentration Analysis, 2025
21.1.1. Concentration Ratio (CR)
21.1.2. Herfindahl Hirschman Index (HHI)
21.2. Recent Developments & Impact Analysis, 2025
21.3. Product Portfolio Analysis, 2025
21.4. Benchmarking Analysis, 2025
21.5. Pfizer Inc.
21.6. BioNTech SE
21.7. Sinovac Biotech Ltd.
21.8. Moderna, Inc.
21.9. Merck & Co., Inc.
21.10. GlaxoSmithKline PLC
21.11. Sanofi S.A.
21.12. Johnson & Johnson Services, Inc.
21.13. AstraZeneca PLC
21.14. Abbott Laboratories
21.15. Astellas Pharma Inc.
21.16. Bavarian Nordic A/S
21.17. Bharat Biotech Ltd.
21.18. Biological E. Limited
21.19. Blue Lake Biotechnology
21.20. Capricor Therapeutics, Inc.
21.21. Chongqing Zhifei Biological Products Co., Ltd.
21.22. CSL Limited
21.23. CureVac N.V.
21.24. Daiichi Sankyo Company, Limited.
21.25. Gennova Biopharmaceuticals Limited
21.26. Haffkine Bio-Pharmaceutical Corporation Ltd.
21.27. Incepta Pharmaceuticals Ltd.
21.28. Inovio Pharmaceuticals, Inc.
21.29. Novavax, Inc.
21.30. Serum Institute of India Pvt. Ltd.
21.31. Takeda Pharmaceutical Company Limited
21.32. VBI Vaccines Inc.
21.33. Versatope Therapeutics
21.34. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL VACCINES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL VACCINES MARKET SIZE, BY DOSAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL VACCINES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VACCINES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. UNITED STATES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 16. CHINA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL VACCINES MARKET SIZE, BY LIVE-ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL VACCINES MARKET SIZE, BY MESSENGER RNA VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL VACCINES MARKET SIZE, BY SUBUNIT, RECOMBINANT, POLYSACCHARIDE, & CONJUGATE VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL VACCINES MARKET SIZE, BY VIRAL VECTOR VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL VACCINES MARKET SIZE, BY MONO-VALENT VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL VACCINES MARKET SIZE, BY MONO-VALENT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL VACCINES MARKET SIZE, BY MONO-VALENT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL VACCINES MARKET SIZE, BY MULTI-VALENT VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL VACCINES MARKET SIZE, BY MULTI-VALENT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL VACCINES MARKET SIZE, BY MULTI-VALENT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL VACCINES MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS A & B, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS A & B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL VACCINES MARKET SIZE, BY HEPATITIS A & B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL VACCINES MARKET SIZE, BY POLIO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL VACCINES MARKET SIZE, BY POLIO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL VACCINES MARKET SIZE, BY COVID-19, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL VACCINES MARKET SIZE, BY COVID-19, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL VACCINES MARKET SIZE, BY COVID-19, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL & MENINGOCOCCAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL & MENINGOCOCCAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL VACCINES MARKET SIZE, BY PNEUMOCOCCAL & MENINGOCOCCAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS HPV, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS HPV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS HPV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL VACCINES MARKET SIZE, BY ROTAVIRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL VACCINES MARKET SIZE, BY DENGUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL VACCINES MARKET SIZE, BY DENGUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL VACCINES MARKET SIZE, BY DENGUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL VACCINES MARKET SIZE, BY MALARIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL VACCINES MARKET SIZE, BY MALARIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL VACCINES MARKET SIZE, BY MALARIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL VACCINES MARKET SIZE, BY RABIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL VACCINES MARKET SIZE, BY RABIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL VACCINES MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL VACCINES MARKET SIZE, BY CANCER VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL VACCINES MARKET SIZE, BY CANCER VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL VACCINES MARKET SIZE, BY ALLERGY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL VACCINES MARKET SIZE, BY ALLERGY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL VACCINES MARKET SIZE, BY ALLERGY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL VACCINES MARKET SIZE, BY ALZHEIMER’S VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL VACCINES MARKET SIZE, BY ALZHEIMER’S VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL VACCINES MARKET SIZE, BY ALZHEIMER’S VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL VACCINES MARKET SIZE, BY PREVENTIVE VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL VACCINES MARKET SIZE, BY THERAPEUTIC VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL VACCINES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL VACCINES MARKET SIZE, BY INTRANASAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL VACCINES MARKET SIZE, BY INTRANASAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL VACCINES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL VACCINES MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL VACCINES MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL VACCINES MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VACCINES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VACCINES MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VACCINES MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL VACCINES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL VACCINES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL VACCINES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL VACCINES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL VACCINES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL VACCINES MARKET SIZE, BY INFANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL VACCINES MARKET SIZE, BY INFANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL VACCINES MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL VACCINES MARKET SIZE, BY TODDLERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL VACCINES MARKET SIZE, BY TODDLERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL VACCINES MARKET SIZE, BY TODDLERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL VACCINES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL VACCINES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL VACCINES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL VACCINES MARKET SIZE, BY VACCINATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL VACCINES MARKET SIZE, BY VACCINATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL VACCINES MARKET SIZE, BY VACCINATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. EUROPE VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. EUROPE VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 181. EUROPE VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 182. EUROPE VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 184. EUROPE VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 185. EUROPE VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 186. EUROPE VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 187. EUROPE VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 188. EUROPE VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 189. EUROPE VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 190. EUROPE VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. AFRICA VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. AFRICA VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 205. AFRICA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 206. AFRICA VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 207. AFRICA VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 208. AFRICA VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 209. AFRICA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 210. AFRICA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. AFRICA VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 212. AFRICA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 213. AFRICA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 214. AFRICA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 228. ASEAN VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. ASEAN VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 230. ASEAN VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 231. ASEAN VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 232. ASEAN VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 233. ASEAN VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 234. ASEAN VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 235. ASEAN VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. ASEAN VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 237. ASEAN VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 238. ASEAN VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 239. ASEAN VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. GCC VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. GCC VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 242. GCC VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 243. GCC VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 244. GCC VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 245. GCC VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 246. GCC VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 247. GCC VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 248. GCC VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 249. GCC VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 250. GCC VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 251. GCC VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. BRICS VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. BRICS VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 266. BRICS VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 267. BRICS VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 268. BRICS VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 269. BRICS VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 270. BRICS VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 271. BRICS VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 272. BRICS VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 273. BRICS VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 274. BRICS VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 275. BRICS VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. G7 VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. G7 VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 278. G7 VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 279. G7 VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 280. G7 VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 281. G7 VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 282. G7 VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 283. G7 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 284. G7 VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 285. G7 VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 286. G7 VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 287. G7 VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. NATO VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. NATO VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 290. NATO VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 291. NATO VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 292. NATO VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 293. NATO VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 294. NATO VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 295. NATO VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 296. NATO VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 297. NATO VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 298. NATO VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 299. NATO VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. CHINA VACCINES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 314. CHINA VACCINES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 315. CHINA VACCINES MARKET SIZE, BY VACCINE COMBINATION, 2018-2032 (USD MILLION)
TABLE 316. CHINA VACCINES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 317. CHINA VACCINES MARKET SIZE, BY INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 318. CHINA VACCINES MARKET SIZE, BY NON-INFECTIOUS DISEASE VACCINES, 2018-2032 (USD MILLION)
TABLE 319. CHINA VACCINES MARKET SIZE, BY VACCINE CLASSIFICATION, 2018-2032 (USD MILLION)
TABLE 320. CHINA VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 321. CHINA VACCINES MARKET SIZE, BY DOSAGE, 2018-2032 (USD MILLION)
TABLE 322. CHINA VACCINES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 323. CHINA VACCINES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
TABLE 324. CHINA VACCINES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Vaccines market report include:
  • Pfizer Inc.
  • BioNTech SE
  • Sinovac Biotech Ltd.
  • Moderna, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • AstraZeneca PLC
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Bavarian Nordic A/S
  • Bharat Biotech Ltd.
  • Biological E. Limited
  • Blue Lake Biotechnology
  • Capricor Therapeutics, Inc.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • CSL Limited
  • CureVac N.V.
  • Daiichi Sankyo Company, Limited.
  • Gennova Biopharmaceuticals Limited
  • Haffkine Bio-Pharmaceutical Corporation Ltd.
  • Incepta Pharmaceuticals Ltd.
  • Inovio Pharmaceuticals, Inc.
  • Novavax, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited
  • VBI Vaccines Inc.
  • Versatope Therapeutics
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 97.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 152.31 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
United States Vaccine Market Report and Forecast 2024-2032 - Product Image

United States Vaccine Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • United States
From
North America Vaccines Market Outlook, 2028 - Product Image

North America Vaccines Market Outlook, 2028

  • Report
  • 101 Pages
  • North America
From
Vaccine Management Solutions - Global Strategic Business Report - Product Image

Vaccine Management Solutions - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Adult Vaccines Market - Global Forecast 2026-2032 - Product Image

Adult Vaccines Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.